CorMedix Inc. (CRMD) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-02-07

CorMedix Inc. (CRMD) — no SEC Form 4 insider filings recorded in the last 90 days. 6 Form 8-K material event filings were reported by CRMD in the last 90 days. InsiderAlpha tracks every CRMD SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About CorMedix Inc. (CRMD)

SEC CIK	0001410098

90-Day SEC Filing Activity

Form 8-K filings (90d)	6
Latest Form 4 filing	2026-02-07

Recent CRMD Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-02-04	Hurlburt Elizabeth	Chief Operating Officer	A — Grant or award	36.0K	$0.00	—	SEC
2026-02-04	Zelnick Kaufman Beth	Chief Legal Officer	A — Grant or award	36.0K	$0.00	—	SEC
2026-02-04	Todisco Joseph	Chief Executive Officer	A — Grant or award	77.2K	$0.00	—	SEC
2026-01-26	Dillione Janet	Director	A — Grant or award	30.5K	$0.00	—	SEC
2026-01-26	Lefkowitz Steven W	Director	A — Grant or award	30.5K	$0.00	—	SEC
2026-01-26	Kaplan Myron	Director	A — Grant or award	30.5K	$0.00	—	SEC
2026-01-26	Duncan Gregory Scott	Director	A — Grant or award	30.5K	$0.00	—	SEC
2026-01-26	Stewart Robert A	Director	A — Grant or award	30.5K	$0.00	—	SEC
2026-01-26	DUNTON ALAN W	Director	A — Grant or award	30.5K	$0.00	—	SEC
2026-01-23	Todisco Joseph	Chief Executive Officer	A — Grant or award	225.9K	$0.00	—	SEC
2026-01-23	Blum Susan	Chief Financial Officer	A — Grant or award	72.8K	$0.00	—	SEC
2026-01-23	Hurlburt Elizabeth	Chief Operating Officer	A — Grant or award	93.0K	$0.00	—	SEC
2026-01-23	Zelnick Kaufman Beth	Chief Legal Officer	F — Tax withholding / forfeiture	8.8K	$7.27	$64K	SEC
2026-01-23	Blum Susan	Chief Financial Officer	F — Tax withholding / forfeiture	9.8K	$7.27	$71K	SEC
2026-01-23	Zelnick Kaufman Beth	Chief Legal Officer	A — Grant or award	72.8K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for CorMedix Inc. (CRMD). Updated in real time as new filings are submitted to the SEC.

Recent CRMD Form 8-K Material Events

2026-07-02 — Item 8.01 [SEC]
2026-07-01 — Item 4.01 [SEC]
2026-06-24 — Item 5.07 [SEC]
2026-06-08 — Item 7.01, 9.01 [SEC]
2026-05-14 — Item 2.02, 9.01 [SEC]

Recent Insider Filings

2026-02-07 — Zelnick Kaufman Beth (Chief Legal Officer)
2026-02-07 — Hurlburt Elizabeth (Chief Operating Officer)
2026-02-07 — Todisco Joseph (Chief Executive Officer)
2026-01-28 — Blum Susan (Chief Financial Officer)
2026-01-28 — Zelnick Kaufman Beth (Chief Legal Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CRMD insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

CRMD Insider Trading — FAQ

What is the latest insider trade for CRMD?: CorMedix Inc. (CRMD) had 0 insider filings in the last 90 days, with the most recent on 2026-02-07. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying CRMD stock?: 0 insider purchases of CRMD were filed in the last 90 days.
How many insiders are selling CRMD stock?: 0 insider sales of CRMD were filed in the last 90 days.
Where can I see CRMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every CRMD SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live CRMD dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.